Introduction
malaria
CURB, DISEASE, MALARIA, COMPLICATION
The world continues to reel under the tragic burden of the COVID-19 pandemic. The medical system was precariously overstretched and scarred. Several drug trials were completed and many more are underway to unravel evidence-based medicine (EBM) for more effective and safe management [It is prudent to state upfront that most of the patients of COVID-19 suffered from asymptomatic or mild and moderate disease and recovered without any complication or sequel [The search to repurpose drugs (COVID-19) also rekindled vigorous research in the traditional, complementary, and alternative systems of medicine (CAM) [India has a legal system to regulate and promote plural systems of medicine including Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa Rigpa, and Homoeopathy, which together are known as AYUSH systems. The Ministry of AYUSH established an Interdisciplinary AYUSH Research and Development Task Force on COVID-19 to promote scientific research and worked closely with the Ministry of Health and Family Welfare to manage and curb the pandemic [The selection of AYUSH-64 was based on Ayurvedic logic and clinical experience. It was initially developed to treat malaria [The current report presents the results of the AYUSH-64 drug trial.